Many Thanks CEO Jeff Meckler. Both 28th Annual ROTH Conference
On Mar. 14th at the Ritz-Carlton Laguna Niguel Hotel in Dana Point, Ca.
and at the Barclays Capital Global Healthcare Conference is all, I wanted,
and probably other investors, wanted to hear that you're getting the word
out on your recent developments. Again, many thanks.
A Long term investor.
Wow, has anyone seen the COCP presentation - Antiviral Therapies? Amazing that COCP is the only company with Drug Resistant Crystals according to the presentation. Also, their Drug-resistant crystal pipeline developed. Finally, that their Technology Platform Focuses on Viral Replication
Drug Targets Through Cocrystalization. For all investors, do your DD. Nonetheless, in my opinion, COCP is a safe bet going forward with it's Technology platform developing new Drug. Please go to their website for more info.